Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2013 1
2014 2
2015 1
2017 1
2018 1
2020 1
2021 1
2022 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Alternative Biologic Therapy in Children Failing Conventional TNFα Inhibitors for Refractory, Noninfectious, Chronic Anterior Uveitis.
Miraldi Utz V, Angeles-Han ST, Mwase N, Cassedy A, Hennard T, Lovell DJ, Lopper S, Brunner HI, Dosunmu EO, Grom AA, Henrickson M, Huggins JL, Sisk RA, Ting TV, Kaufman AH. Miraldi Utz V, et al. Among authors: dosunmu eo. Am J Ophthalmol. 2022 Dec;244:183-195. doi: 10.1016/j.ajo.2022.06.024. Epub 2022 Jul 19. Am J Ophthalmol. 2022. PMID: 35863492 Clinical Trial.
CHARGE syndrome without colobomas: Ophthalmic findings.
Dosunmu EO, Castleberry KM. Dosunmu EO, et al. Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):611-617. doi: 10.1002/ajmg.c.31840. Epub 2020 Sep 10. Am J Med Genet C Semin Med Genet. 2020. PMID: 32914532
Mimickers of age-related macular degeneration.
Dosunmu EO, Bakri SJ. Dosunmu EO, et al. Semin Ophthalmol. 2011 May;26(3):209-15. doi: 10.3109/08820538.2011.577134. Semin Ophthalmol. 2011. PMID: 21609234 Review.
Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.
Writing Committee for the Pediatric Eye Disease Investigator Group; Hartnett ME, Wallace DK, Dean TW, Li Z, Boente CS, Dosunmu EO, Freedman SF, Golden RP, Kong L, Prakalapakorn SG, Repka MX, Smith LE, Wang H, Kraker RT, Cotter SA, Holmes JM. Writing Committee for the Pediatric Eye Disease Investigator Group, et al. Among authors: dosunmu eo. JAMA Ophthalmol. 2022 Apr 1;140(4):337-344. doi: 10.1001/jamaophthalmol.2022.0030. JAMA Ophthalmol. 2022. PMID: 35446359 Free PMC article.
Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes.
Freedman SF, Hercinovic A, Wallace DK, Kraker RT, Li Z, Bhatt AR, Boente CS, Crouch ER, Hubbard GB, Rogers DL, VanderVeen D, Yang MB, Cheung NL, Cotter SA, Holmes JM; Pediatric Eye Disease Investigator Group. Freedman SF, et al. Ophthalmology. 2022 Oct;129(10):1120-1128. doi: 10.1016/j.ophtha.2022.05.019. Epub 2022 Jun 1. Ophthalmology. 2022. PMID: 35660415 Free PMC article.
11 results